REGγ regulates ERα degradation via ubiquitin-proteasome pathway in breast cancer

Biochemical and Biophysical Research Communications

Volumn 456, Issue 1, 2015, Pages 534-540

  Chai, Fan ^a   Liang, Yan ^a   Bi, Jiong ^b   Chen, Li ^a   Zhang, Fan ^a   Cui, Youhong ^a   Jiang, Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Breast cancer; Degradation; ER ; Proteasome; REG ; Ubiquitin

Indexed keywords

ESTROGEN RECEPTOR ALPHA; NUCLEAR PROTEIN; PROTEASOME; REGGAMMA PROTEIN; SMALL INTERFERING RNA; UBIQUITIN; UNCLASSIFIED DRUG; AUTOANTIGEN; ESTROGEN RECEPTOR ALPHA, HUMAN; KI ANTIGEN;

ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENICITY; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; OVERALL SURVIVAL; PROTEIN DEGRADATION; ADULT; AGED; BREAST TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MCF 7 CELL LINE; METABOLISM; MIDDLE AGED; TUMOR CELL LINE; TUMOR INVASION;

EUKARYOTA;

ADULT; AGED; AUTOANTIGENS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, SMALL INTERFERING; UBIQUITIN;

EID: 84919660617     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.11.124     Document Type: Article

References (30)

1. T. Nikaido, K. Shimada, M. Shibata, M. Hata, M. Sakamoto, Y. Takasaki, C. Sato, T. Takahashi, and Y. Nishida Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus Clin. Exp. Immunol. 79 1990 209 214
2. C.P. Ma, C.A. Slaughter, and G.N. DeMartino Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain) J. Biol. Chem. 267 1992 10515 10523
3. P. Masson, O. Andersson, U.M. Petersen, and P. Young Identification and characterization of a Drosophila nuclear proteasome regulator. A homolog of human 11 S REGgamma (PA28gamma) J Biol. Chem. 276 2001 1383 1390
4. X. Gao, J. Li, G. Pratt, S. Wilk, and M. Rechsteiner Purification procedures determine the proteasome activation properties of REG gamma (PA28 gamma) Arch. Biochem. Biophys. 425 2004 158 164
5. I. Mao, J. Liu, X. Li, and H. Luo REGgamma, a proteasome activator and beyond? Cell. Mol. Life Sci. 65 2008 3971 3980
6. M. Tian, W. Xiaoyi, L. Xiaotao, and R. Guosheng Proteasomes reactivator REGgamma enhances oncogenicity of MDA-MB-231 cell line via promoting cell proliferation and inhibiting apoptosis Cell. Mol. Biol. (Noisy-le-grand) 55 Suppl. 2009 OL1121 OL1131
7. X. Wang, S. Tu, J. Tan, T. Tian, L. Ran, J.F. Rodier, and G. Ren REGgamma: a potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell Med. Oncol. 28 2011 31 41
8. M. Zhang, L. Gan, and G.S. Ren REGgamma is a strong candidate for the regulation of cell cycle, proliferation and the invasion by poorly differentiated thyroid carcinoma cells Braz. J. Med. Biol. Res. 45 2012 459 465
9. H.L. Jia, Q.H. Ye, L.X. Qin, A. Budhu, M. Forgues, Y. Chen, Y.K. Liu, H.C. Sun, L. Wang, H.Z. Lu, F. Shen, Z.Y. Tang, and X.W. Wang Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma Clin. Cancer Res. 13 2007 1133 1139
10. X. Jiang, J. Tan, J. Li, S. Kivimae, X. Yang, L. Zhuang, P.L. Lee, M.T. Chan, L.W. Stanton, E.T. Liu, B.N. Cheyette, and Q. Yu DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications Cancer Cell 13 2008 529 541
11. A. Ali, Z. Wang, J. Fu, L. Ji, J. Liu, L. Li, H. Wang, J. Chen, C. Caulin, J.N. Myers, P. Zhang, J. Xiao, B. Zhang, and X. Li Differential regulation of the REGgamma-proteasome pathway by p53/TGF-beta signalling and mutant p53 in cancer cells Nat. Commun. 4 2013 2667
12. J. Liu, G. Yu, Y. Zhao, D. Zhao, Y. Wang, L. Wang, J. Liu, L. Li, Y. Zeng, Y. Dang, C. Wang, G. Gao, W. Long, D.M. Lonard, S. Qiao, M.J. Tsai, B. Zhang, H. Luo, and X. Li REGgamma modulates p53 activity by regulating its cellular localization J. Cell Sci. 123 2010 4076 4084
13. X. Li, D.M. Lonard, S.Y. Jung, A. Malovannaya, Q. Feng, J. Qin, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome Cell 124 2006 381 392
14. X. Chen, L.F. Barton, Y. Chi, B.E. Clurman, and J.M. Roberts Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome Mol. Cell 26 2007 843 852
15. F. Bray, J.S. Ren, E. Masuyer, and J. Ferlay Global estimates of cancer prevalence for 27 sites in the adult population in 2008 Int. J. Cancer 132 2013 1133 1145
16. I.S.J. Ferlay, M. Ervik, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D. M. Parkin, D. Forman, F. Bray, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet], GLOBOCAN 1.0, 2012.
17. G.W. Woodfield, M.J. Hitchler, Y. Chen, F.E. Domann, and R.J. Weigel Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure Clin. Cancer Res. 15 2009 3672 3679
18. P.A. Madureira, R. Varshochi, D. Constantinidou, R.E. Francis, R.C. Coombes, K.M. Yao, and E.W. Lam The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells J. Biol. Chem. 281 2006 25167 25176
19. N. Kondo, T. Toyama, H. Sugiura, Y. Fujii, and H. Yamashita MiR-206 expression is down-regulated in estrogen receptor alpha-positive human breast cancer Cancer Res. 68 2008 5004 5008
20. A. Nakajima, S. Maruyama, M. Bohgaki, N. Miyajima, T. Tsukiyama, N. Sakuragi, and S. Hatakeyama Ligand-dependent transcription of estrogen receptor alpha is mediated by the ubiquitin ligase EFP Biochem. Biophys. Res. Commun. 357 2007 245 251
21. N.B. Berry, M. Fan, and K.P. Nephew Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome Mol. Endocrinol. 22 2008 1535 1551
22. N.M. Kretzer, M.T. Cherian, C. Mao, I.O. Aninye, P.D. Reynolds, R. Schiff, P.J. Hergenrother, S.K. Nordeen, E.M. Wilson, and D.J. Shapiro A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha} J. Biol. Chem. 285 2010 41863 41873
23. H. Liu, J. Qiu, N. Li, T. Chen, and X. Cao Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src J. Biol. Chem. 285 2010 21934 21942
24. I.F. Lu, A.C. Hasio, M.C. Hu, F.M. Yang, and H.M. Su Docosahexaenoic acid induces proteasome-dependent degradation of estrogen receptor alpha and inhibits the downstream signaling target in MCF-7 breast cancer cells J. Nutr. Biochem. 21 2010 512 517
25. T.A. Petrel, and R.W. Brueggemeier Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines J. Cell Biochem. 88 2003 181 190
26. Z. Nawaz, D.M. Lonard, A.P. Dennis, C.L. Smith, and B.W. O'Malley Proteasome-dependent degradation of the human estrogen receptor Proc. Natl. Acad. Sci. U.S.A. 96 1999 1858 1862
27. Y. Wang, H. Zong, Y. Chi, Y. Hong, Y. Yang, W. Zou, X. Yun, and J. Gu Repression of estrogen receptor alpha by CDK11p58 through promoting its ubiquitin-proteasome degradation J. Biochem. 145 2009 331 343
28. A.L. Wijayaratne, and D.P. McDonnell The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators J. Biol. Chem. 276 2001 35684 35692
29. A.P. Dennis, R.U. Haq, and Z. Nawaz Importance of the regulation of nuclear receptor degradation Front. Biosci. 6 2001 D954 D959
30. M. Fan, E.L. Rickert, L. Chen, S.A. Aftab, K.P. Nephew, and R.V. Weatherman Characterization of molecular and structural determinants of selective estrogen receptor downregulators Breast Cancer Res. Treat. 103 2007 37 44